AIFF PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d

AIFF ▼ -24.17% at T+20d

NEUTRAL call ✗ call lost -24.17% · α vs SPY -34.84% · entry $3.02 → $2.29

Next anchor: T+60d in 13d

Currently $1.61 · -46.69% from $3.02 entry

Entry anchored
Mar 26, 07:37 AM ET
via Databento tick

T+1d

-27.81%

call -27.81% · α -26.13%

$2.18

settled 3mo ago

T+5d

-29.80%

call -29.80% · α -31.43%

$2.12

settled 2mo ago

T+20d

-24.17%

call -24.17% · α -34.84%

$2.29

settled 7w ago

T+60d

—

call — · α —

—

in 13d

Price Chart

Loading chart...

Executive Summary

Firefly Neuroscience announced a partnership with the Department of War to deploy its FDA-cleared, AI-powered EEG/ERP technology for assessing and treating PTSD and TBI in U.S. service members. While the deal expands Firefly’s commercial footprint into the defense and government health sectors, specific financial terms and scale of deployment were not disclosed.

Actionable Insight

Traders should monitor for future disclosures on contract value, government procurement filings, or additional deployment details. The lack of financial terms limits immediate impact, but this could be a foundational deal for scaling in the public sector.

Key Facts

Firefly Neuroscience (AIFF) announced a partnership with the Department of War (DoW) to support assessment and treatment of PTSD and TBI in active-duty and veteran service members.
The partnership leverages Firefly’s FDA 510(k)-cleared, AI-powered EEG/ERP platform to provide objective neurological data for diagnosis and treatment tracking.
Specific financial terms, contract value, duration, and deployment scale are not disclosed and remain confidential.
The company highlights the multi-billion-dollar economic burden of PTSD and TBI in the military as a key market opportunity.
This represents a strategic expansion into U.S. government and defense health sectors, supporting Firefly’s commercial and data-gathering initiatives.

Financial Impact

Unknown — no financial terms disclosed; potential long-term revenue upside from government contracts but no immediate quantifiable impact.

revenuemarket perceptioncommercial expansion

Risk Factors

No disclosed financial value or timeline reduces near-term revenue visibility.
Government contracts often involve long sales cycles, regulatory hurdles, and funding uncertainties.
Forward-looking statements dominate the release; actual adoption and reimbursement remain unproven.

Market Snapshot

Exchange

Nasdaq

Sector

Services-Prepackaged Software

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3262902

3 reports for AIFF

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for AIFF — sortable, filterable
	Type				Now
May 12, 2026 28d ago	8-K BEARISH ★ 6/10	$1.80 $1.66	▲ +7.78%	▲ +6.62%	$1.61 (+10.56%)
Apr 22, 2026 6w ago	8-K NEUTRAL ★ 5/10	$2.06 $1.98	▼ −3.88%	▼ −5.36%	$1.61 (−21.84%)
Mar 26, 2026 10w ago	Press Release MIXED ★ 6/10	$3.02 $2.12	▼ −29.80%	▼ −31.43%	$1.61 (−46.69%)

US Market Status

Market Closed — Opens Thu (10h 13m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access